State Of Wyoming Forma Therapeutics Holdings, Inc. Transaction History

State Of Wyoming

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$5.1 - $10.0 $668 - $1,310	-131 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$8.34 - $14.69 $333 - $587	-40 Reduced 23.39%	131 $1,000
Q4 2021 Feb 11, 2022	SELL	$13.6 - $24.89 $13 - $24	-1 Reduced 0.58%	171 $2,000
Q3 2021 Feb 11, 2022	SELL	$21.22 - $25.7 $2,270 - $2,749	-107 Reduced 38.35%	172 $4,000
Q2 2021 Feb 11, 2022	BUY	$22.86 - $30.95 $3,268 - $4,425	143 Added 105.15%	279 $7,000
Q1 2021 Feb 08, 2022	BUY	$24.58 - $42.82 $3,342 - $5,823	136 New	136 $4,000

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.